tirzepatide launch Exciting new Semaglutide & product Eli Lilly launches weight-loss drug

Eli Lilly, meanwhile, has been on a tear

3.2 Indications: The approved indications for SGLT2 inhibitors include: Diabetes mellitus Heart failure Chronic kidney disease 3.3 Benefits and Harms of Continuation/Discontinuation in the Perioperative Period: 3.3.1 Benefits: Improved Glycemic Control: Continued use may help maintain stable blood glucose levels

When to Contact Your Care Team About a Missed Dose You don't need to alert your care team about a single missed injection if you've already self-corrected your schedule

The Week 72 analysis included 800 F2 and F3 (at eligibility) patients randomized 1:2 to receive placebo (n=266) or WEGOVY once weekly (n=534), in addition to standard of care for cardiometabolic comorbidities and healthy lifestyle counseling